What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical an...

por Andrea Palicelli, Martina Bonacini, Stefania Croci, Cristina Magi-Galluzzi, Sofia Cañete-Portillo, Alcides Chaux, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Daniel Athanazio, Jatin Gandhi, Alberto Cavazza, Giacomo Santandrea, Alessandro Tafuni, Magda Zanelli
Publicado 2021

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review

por Giorgio Ivan Russo, Giuseppe Broggi, Andrea Cocci, Paolo Capogrosso, Marco Falcone, Ioannis Sokolakis, Murat Gül, Rosario Caltabiano, Marina Di Mauro
Publicado 2021

New Polyesterified Ursane Derivatives from Leaves of <i>Maesa membranacea</i> and Their Cytotoxic Activity

por Klaudia Michalska, Agnieszka Galanty, Thanh Nguyen Le, Janusz Malarz, Nguyen Quoc Vuong, Van Cuong Pham, Anna Stojakowska
Publicado 2021

Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8+ T Cells and Macrophages

por Luo ZW, Xia K, Liu YW, Liu JH, Rao SS, Hu XK, Chen CY, Xu R, Wang ZX, Xie H
Publicado 2021

Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis

por Pang B, Zhu Y, Ni J, Ruan J, Thompson J, Malouf D, Bucci J, Graham P, Li Y
Publicado 2020

The Role of microRNA-15A in the Development of Prostate Cancer – Effects on Cell Proliferation and Pro-Inflammatory Signalling

por Apostolova A., Sezer L., Hayrabedyan S., Todorova Kr.
Publicado 2018

Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles

por Winter A, Kowald T, Paulo TS, Goos P, Engels S, Gerullis H, Schiffmann J, Chavan A, Wawroschek F
Publicado 2018

Optical coding of fusion genes using multicolor quantum dots for prostate cancer diagnosis

por Lee H, Kim C, Lee D, Park JH, Searson PC, Lee KH
Publicado 2017

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa

por William Swanson, William Swanson, Richard Ndi Samba, Michael Lavelle, Ahmed Elzawawy, Erno Sajo, Wilfred Ngwa, Wilfred Ngwa, Luca Incrocci
Publicado 2021

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer

por Zhang G, Luo Y
Publicado 2021

Self-assembled albumin nanoparticles for combination therapy in prostate cancer

por Lian H, Wu J, Hu Y, Guo H
Publicado 2017

Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool

por Fatemeh Khatami, Mandana Hasanzad
Publicado 2020

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia

por Shao IH, Hou CP, Chen SM, Chen CL, Lin YH, Chang PL, Tsui KH
Publicado 2013

Degarelix and its therapeutic potential in the treatment of prostate cancer

por Christian Doehn, Martin Sommerauer, Dieter Jocham
Publicado 2009

Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study

por Xianghong Zhou, Shi Qiu, Kun Jin, Qiming Yuan, Di Jin, Zilong Zhang, Xiaonan Zheng, Jiakun Li, Qiang Wei, Lu Yang
Publicado 2021

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer

por Qu N, Lee RJ, Sun Y, Cai G, Wang J, Wang M, Lu J, Meng Q, Teng L, Wang D, Teng L
Publicado 2016

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

por Tunn UW, Gruca D, Bacher P
Publicado 2013

Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway

por Wang Y, Yang QW, Yang Q, Zhou T, Shi MF, Sun CX, Gao XX, Cheng YQ, Cui XG, Sun YH
Publicado 2017

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

por Archibald M, Pritchard T, Nehoff H, Rosengren RJ, Greish K, Taurin S
Publicado 2016

Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?

por William John Yaxley, Rhiannon McBean, David Wong, David Grimes, Paul Vasey, Mark Frydenberg, John William Yaxley
Publicado 2021